THE PITUITARY SOCIETY INC

EIN: 223307141 501(c)(3) Diseases & Disorders

LOS ANGELES, CA

Total Revenue
$753,709
Total Expenses
$483,415
Total Assets
$3,079,505
Net Assets
$2,390,266
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1994
Legal Domicile
DE
Principal Officer
DR SHLOMO MELMED
Phone
3109889486
Tax Period
2024-07-01 to 2025-06-30

THE PITUITARY SOCIETY INC, founded in 1994, is a small nonprofit in the Diseases & Disorders sector that reported $754K in total revenue in fiscal year 2024. Revenue surged 37% from the prior year, signaling strong growth momentum. The organization ran a surplus of $270K, a strong 36% operating margin.

Mission

OUR MISSION IS TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE.

Program Service Accomplishments

Program 1
Expenses: $100,100 Revenue: $2,230

GROPRO CONFERENCETHE GROWTH HORMONE (GH)/ PROLACTIN (PRL) FAMILY IN BIOLOGY & DISEASE CONFERENCE (GROPRO) WAS HELD AUGUST 11-15, 2024, IN STIRLING, SCOTLAND. THIS CONFERENCE USED TO BE ASSOCIATED...

Read more

GROPRO CONFERENCETHE GROWTH HORMONE (GH)/ PROLACTIN (PRL) FAMILY IN BIOLOGY & DISEASE CONFERENCE (GROPRO) WAS HELD AUGUST 11-15, 2024, IN STIRLING, SCOTLAND. THIS CONFERENCE USED TO BE ASSOCIATED WITH FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY (FASEB) AND BEFORE THAT WITH THE GORDON CONFERENCES. SO, IT HAS LONG HISTORY, OVER 2 DECADES. THIS ITERATION OF THE CONFERENCE WAS HELD IN ASSOCIATION WITH THE PITUITARY SOCIETY. THIS CONFERENCE WAS HELD IN EUROPE FOR THE FIRST TIME WITH OVER 90 SCIENTISTS, PHYSICIANS, AND TRAINEES IN ATTENDANCE.THE SCIENTIFIC THEME OF THIS CONFERENCE IS TO IMPROVE OUR UNDERSTANDING OF THE REGULATION AND ACTION OF GH AND PRL AND THEIR SPECIFIC RECEPTORS AS WELL AS THEIR ROLE IN DISEASE PROMOTION OR PREVENTION.

Program 2
Expenses: $18,648

PRECEPTORSHIP COURSE FOR FELLOWS-IN-TRAININGTHIS COURSE, HELD IN JANUARY 2025, WAS THE SEVENTH SINCE ITS INCEPTION. THE COURSE WAS ATTENDED BY APPROXIMATELY 225 FELLOWS-IN-TRAINING. FELLOWS WERE...

Read more

PRECEPTORSHIP COURSE FOR FELLOWS-IN-TRAININGTHIS COURSE, HELD IN JANUARY 2025, WAS THE SEVENTH SINCE ITS INCEPTION. THE COURSE WAS ATTENDED BY APPROXIMATELY 225 FELLOWS-IN-TRAINING. FELLOWS WERE REQUIRED TO SUBMIT AN INTERESTING PITUITARY CASE TO ATTEND THE COURSE. CASES WERE REVIEWED BY FACULTY AND FOUR-TO-SIX WERE SELECTED TO BE PRESENTED BY THE FELLOWS DURING THE CASE DISCUSSION. FACULTY RECORDED PRESENTATIONS ON ALL PITUITARY PATHOLOGY WERE VIEWED BY THE FELLOWS PRIOR TO THE LIVE WEBINARS TO ALLOW FOR MORE INTERACTIVE LEARNING.OVER THE LAST DECADE, MANY ENDOCRINOLOGY FELLOWSHIP PROGRAMS REDUCED THE TRAINING REQUIREMENTS FROM 3 YEARS TO 2 YEARS TO BE ELIGIBLE FOR BOARD CERTIFICATION. IN PARALLEL, DIABETES AND OBESITY INCIDENCE AND PREVALENCE INCREASED SIGNIFICANTLY, LIMITING CLINICAL EXPERIENCES ON OTHER RARER, NEVERTHELESS SEVERE AND POTENTIALLY LETHAL DISEASES, SUCH AS PITUITARY DISORDERS. THEREFORE, THIS COURSE TAUGHT BY LEADING INTERNATIONAL EXPERTS, ADDRESSED SOME OF THESE ISSUES BY REVIEWING FOR TRAINEES ADVANCEMENTS IN DIAGNOSIS AND TREATMENT OF HYPOPITUITARISM, GROWTH HORMONE DEFICIENCY, CUSHING'S SYNDROME AND ACROMEGALY AS WELL AS MANAGEMENT OF PITUITARY DISEASE IN THE POST-COVID ERA.

Program 3
Expenses: $10,000

PITUITARY SOCIETY CONSENSUS GUIDELINE FOR PITUITARY INCIDENTALOMAS (PUBLISHED GUIDELINE)WITHIN THE CONSTRAINTS OF LIMITED EVIDENCE-BASED REPORTS, THIS PITUITARY SOCIETY CONSENSUS SUMMARIZES THE...

Read more

PITUITARY SOCIETY CONSENSUS GUIDELINE FOR PITUITARY INCIDENTALOMAS (PUBLISHED GUIDELINE)WITHIN THE CONSTRAINTS OF LIMITED EVIDENCE-BASED REPORTS, THIS PITUITARY SOCIETY CONSENSUS SUMMARIZES THE EPIDEMIOLOGY AND NATURAL HISTORY, DIAGNOSTIC WORK-UP, AND TREATMENT OPTIONS FOR PATIENTS WITH PITUITARY INCIDENTALOMAS. WE DISTINGUISH BETWEEN PITUITARY ADENOMAS AND OTHER TYPES OF INCIDENTALOMAS AND PARTICULARLY DISTINGUISH BETWEEN MICROADENOMAS AND MACROADENOMAS GIVEN THE LOWER LIKELIHOOD OF THE LATTER TO BE A TRULY INCIDENTAL FINDING.THE GUIDELINES WERE PUBLISHED IN NATURE REVIEWS ENDOCRINOLOGY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $694,053
Program Service Revenue $2,230
Investment Income $56,433
Other Revenue $993
TOTAL REVENUE $753,709

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $128,748
Other Expenses $483,415
TOTAL EXPENSES $483,415

Year-over-Year Comparison

2024 2023 Change
Revenue $753,709 $551,129 +0.4%
Expenses $483,415 $488,822 0.0%
Net Income $270,294 $62,307 +3.3%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
13
Employees
N/A
Volunteers
63

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
6
$0
Total Directors
13
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
RICHARD ROSS MBBS MD FRCP PRESIDENT 6.00
Officer Director
$0 $0 $0
SHLOMO MELMED MB CHB MACP FRCP SECRETARY-TREASURER 6.00
Officer Director
$0 $0 $0
KEN HO MD CO-DIRECTOR, PROGRAMS 0.30
Officer Director
$0 $0 $0
MARIA FLESERIU MD FACE CO-DIRECTOR, PROGRAMS 0.30
Officer Director
$0 $0 $0
FELIPE F CASANUEVA MD PHD INTERNATIONAL RELATIONS 0.30
Officer Director
$0 $0 $0
ANDREA GIUSTINA MD EDITOR, PITUITARY 0.30
Officer Director
$0 $0 $0
NIENKE BIERMASZ MD PHD DIRECTOR 0.30
Director
$0 $0 $0
ELIZA GEERMD DIRECTOR 0.30
Director
$0 $0 $0
LISA NACHTIGALL MD DIRECTOR 0.30
Director
$0 $0 $0
ROSARIO PIVONELLO MD PHD DIRECTOR 0.30
Director
$0 $0 $0
GUDMUNDUR JOHANNSSON MD PHD DIRECTOR 0.30
Director
$0 $0 $0
ANN MCCORMACK MBBS DIRECTOR 0.30
Director
$0 $0 $0
KEVIN YUEN MD DIRECTOR 0.30
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $753,709 $483,415 $3,079,505 $270,294
2024 $551,129 $488,822 $2,128,717 $62,307
2023 $798,095 $549,749 $2,298,432 $248,346
2022 $287,129 $206,827 $1,840,975 $80,302
2021 $725,632 $269,494 $1,765,158 $456,138
2020 $447,437 $236,740 $1,458,060 $210,697
2019 $959,994 $659,846 $1,185,286 $300,148
2018 $108,569 $255,740 $931,391 $-147,171
Explore More Nonprofits
Top 100 Nonprofits in California Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare THE PITUITARY SOCIETY INC with other nonprofits in California and across the country.